BIBLIOGRAPHY

This new section of the site is dedicated to articles related to clemastine, and provides detailed and analytical information for professional use.

These scientific documents focus primarily on its use, and cover specific areas such as medical studies, the latest clinical research and new advances taking place within the pharmaceutical industry.

If you cannot find a specific article in the chronological archives below, you can use the SEARCH box situated on the left hand column.

 

Administration of clemastine--H1 histamine receptor blocker in the prevention of haemodynamic disorders after protamine sulfate administration in patients subjected to coronary artery bypass grafting in extracorporeal circulation.

Introduction: Adverse effects of protamine administration after CPB: fall in arterial blood pressure and pulmonary hypertension are still a source of problems. CPB and protamine administration are both accompanied by increased...

Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.

Human ether-a-go-go-related gene (HERG) encodes the alpha-subunit of channels carrying the cardiac rapid delayed K+ current (Ikr), which is a major determinant of the duration of ventricular action potentials (APs) and of the QT...

Displaying results 1 to 5 out of 28

1

2

3

4

5

6

Next >

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.